Serum milk fat globule-EGF factor 8 (MFG-E8) as a diagnostic and prognostic biomarker in patients with hepatocellular carcinoma

[1]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[2]  Ni Li,et al.  Direct comparison of five serum biomarkers in early diagnosis of hepatocellular carcinoma , 2018, Cancer management and research.

[3]  Y. Maehara,et al.  MicroRNA‐125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection , 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

[4]  G. Tan,et al.  Integrin-β5, a miR-185-targeted gene, promotes hepatocellular carcinoma tumorigenesis by regulating β-catenin stability , 2018, Journal of Experimental & Clinical Cancer Research.

[5]  R. Desert,et al.  Human hepatocellular carcinomas with a periportal phenotype have the lowest potential for early recurrence after curative resection , 2017, Hepatology.

[6]  Myeong Jun Song,et al.  Milk Fat Globule-EGF Factor 8, Secreted by Mesenchymal Stem Cells, Protects Against Liver Fibrosis in Mice. , 2017, Gastroenterology.

[7]  Sang Gyune Kim,et al.  Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma , 2017, Medicine.

[8]  Zubang Zhou,et al.  Reduced serum milk fat globule-epidermal growth factor 8 (MFG-E8) concentrations are associated with an increased risk of microvascular complications in patients with type 2 diabetes. , 2017, Clinica chimica acta; international journal of clinical chemistry.

[9]  G. Iribe,et al.  Cardiac myofibroblast engulfment of dead cells facilitates recovery after myocardial infarction , 2017, The Journal of clinical investigation.

[10]  Joshua M. Weiss,et al.  Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis. , 2016, Cancer cell.

[11]  Diego Diez,et al.  A novel affinity-based method for the isolation of highly purified extracellular vesicles , 2016, Scientific Reports.

[12]  Tzeng-Ji Chen,et al.  Antiplatelet Therapy is Associated with a Better Prognosis for Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma after Liver Resection , 2016, Annals of Surgical Oncology.

[13]  H. Völzke,et al.  Milk Fat Globule‐Epidermal Growth Factor 8 (MFG‐E8) Is a Novel Anti‐inflammatory Factor in Rheumatoid Arthritis in Mice and Humans , 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  G. Gores,et al.  Hepatocellular carcinoma , 2016, Nature Reviews Disease Primers.

[15]  Keigo Saito,et al.  Biomarkers for the early diagnosis of hepatocellular carcinoma. , 2015, World journal of gastroenterology.

[16]  W. Landis,et al.  Matrix vesicles: Are they anchored exosomes? , 2015, Bone.

[17]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[18]  C. Théry,et al.  Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. , 2014, Annual review of cell and developmental biology.

[19]  L. Mariani,et al.  Resection of hepatocellular cancer ≤2 cm: Results from two Western centers , 2013, Hepatology.

[20]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[21]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[22]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[23]  J. Bruix,et al.  Management of HCC. , 2012, Journal of hepatology.

[24]  A. Matsuda,et al.  Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation , 2011, Apoptosis.

[25]  Y. Shibayama,et al.  Clinicopathological Risk Factors for Recurrence within One Year after Initial Hepatectomy for Hepatocellular Carcinoma , 2011, The American surgeon.

[26]  S. Fan,et al.  Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma: A 20-Year Experience , 2011, Annals of surgery.

[27]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[28]  F. Piscaglia,et al.  Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. , 2010, Journal of hepatology.

[29]  P. Chow,et al.  Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. , 2009, The Lancet. Oncology.

[30]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[31]  J. Marrero,et al.  Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. , 2009, Gastroenterology.

[32]  J. Takagi,et al.  Milk fat globule EGF factor 8 in the serum of human patients of systemic lupus erythematosus , 2008, Journal of leukocyte biology.

[33]  Petra Schwille,et al.  Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.

[34]  S. Nagata,et al.  Identification of Tim4 as a phosphatidylserine receptor , 2007, Nature.

[35]  J. Marrero,et al.  Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: a comparison of AFP, DCP, and AFP-L3. , 2007, Cancer biomarkers : section A of Disease markers.

[36]  S. Gallinger,et al.  Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. , 2006, Journal of the American College of Surgeons.

[37]  C. Théry,et al.  Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. , 2005, Blood cells, molecules & diseases.

[38]  L. Boscá,et al.  Prostaglandin E2 promotes migration and adhesion in hepatocellular carcinoma cells. , 2005, Carcinogenesis.

[39]  B. Daniele,et al.  α-fetoprotein and ultrasonography screening for hepatocellular carcinoma , 2004 .

[40]  S. Nagata,et al.  Autoimmune Disease and Impaired Uptake of Apoptotic Cells in MFG-E8-Deficient Mice , 2004, Science.

[41]  M. Fiorentino,et al.  Expression, regulation, and function of αV integrins in hepatocellular carcinoma: An in vivo and in vitro study , 2002 .

[42]  Keiko Miwa,et al.  Identification of a factor that links apoptotic cells to phagocytes , 2002, Nature.

[43]  J. Rasmussen,et al.  Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domains. , 1997, Biochemistry.

[44]  D. Woodfield.  Hepatocellular carcinoma. , 1986, The New Zealand medical journal.